Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Agreement TerminatedItem 1.02 · 8-KMEDIUM RiskNegative

Passage Bio, Inc.

comhomedefault.aspx
Filed: Mar 4, 2026PhiladelphiaCIK: 1787297Healthcare
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Passage Bio terminated its lease for 62,000 square feet of laboratory space at Hopewell Campus, paying approximately $4.8 million in termination fees. This significant real estate exit could materially impact the company's operational capabilities and financial position.

Key Takeaways

Passage Bio paid $4.8 million to terminate the Hopewell lease, which covered 62,000 square feet of laboratory space

The original lease agreement dated December 15, 2020 had a 15-year term, indicating early termination

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMar 4, 2026
Item1.02
CategoryAgreement Terminated
CIK1787297
Accession #0001787297
Risk LevelMEDIUM
SentimentNegative
Signalrisk
Topics
real estaterestructuring

What This Means

A material agreement has been terminated. This could indicate a breakdown in a business relationship or strategic pivot.
View Full Filing on SEC.govBrowse More Filings